Scholarlink

Background <p>The introduction of digital health applications (DiGAs) in the German healthcare system has enabled scalable access to guideline-recommended treatment for chronic insomnia. Since October 2020, the DiGA <i>somnio</i> has been available for prescription by practitioners offering digital cognitive behavioural therapy for insomnia (CBT-I) for patients with an insomnia diagnosis. The availability of user data now allows us to investigate the effects of digital CBT‑I as part of standard care for the first time.</p> Objective <p>An analysis of user data derived from the digital CBT‑I intervention <i>somnio </i>will provide a&#xa0;more comprehensive understanding of its impact, benefits, and acceptability within primary care.</p> Materials and methods <p>We analysed data from <i>N</i> = 5000 randomly selected users who completed <i>somnio</i> between 2021 and 2022 and reported an insomnia severity index (ISI) score ≥ 8 at the start of the intervention. Insomnia severity (ISI) and sleep behaviour were evaluated descriptively over the course of the digital intervention. Cohen’s&#xa0;d for within-group changes was calculated to provide information on effect measures.</p> Results <p>Our analysis revealed a&#xa0;reduction in insomnia severity of −8.49 ± 5.39 points on the ISI between the start and the end of the programme (d = 1.58). At completion, 57% met the response criteria (reduction ≥ 8&#xa0;points on the ISI) and 38% met the criteria for remission (ISI &lt; 8). Evaluation of diary entries showed a&#xa0;large improvement in sleep continuity and quality over time (ds = 0.68–1.07).</p> Conclusion <p>Consistent with controlled studies, our real-world data suggest that digital CBT-I&#xa0;can yield clinically meaningful improvements in sleep and the ISI. The results support implementation of digital therapeutics within primary care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Real-world evidence for the use of digital cognitive behavioural therapy for insomnia within primary care

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月20日

查看全文
  • Leonie Franziska Maurer,
  • Felix Aust,
  • Noah Lorenz

摘要

Background

The introduction of digital health applications (DiGAs) in the German healthcare system has enabled scalable access to guideline-recommended treatment for chronic insomnia. Since October 2020, the DiGA somnio has been available for prescription by practitioners offering digital cognitive behavioural therapy for insomnia (CBT-I) for patients with an insomnia diagnosis. The availability of user data now allows us to investigate the effects of digital CBT‑I as part of standard care for the first time.

Objective

An analysis of user data derived from the digital CBT‑I intervention somnio will provide a more comprehensive understanding of its impact, benefits, and acceptability within primary care.

Materials and methods

We analysed data from N = 5000 randomly selected users who completed somnio between 2021 and 2022 and reported an insomnia severity index (ISI) score ≥ 8 at the start of the intervention. Insomnia severity (ISI) and sleep behaviour were evaluated descriptively over the course of the digital intervention. Cohen’s d for within-group changes was calculated to provide information on effect measures.

Results

Our analysis revealed a reduction in insomnia severity of −8.49 ± 5.39 points on the ISI between the start and the end of the programme (d = 1.58). At completion, 57% met the response criteria (reduction ≥ 8 points on the ISI) and 38% met the criteria for remission (ISI < 8). Evaluation of diary entries showed a large improvement in sleep continuity and quality over time (ds = 0.68–1.07).

Conclusion

Consistent with controlled studies, our real-world data suggest that digital CBT-I can yield clinically meaningful improvements in sleep and the ISI. The results support implementation of digital therapeutics within primary care.